- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Tübingen, Universität Tübingen, Dissertation, 2018
- Schlagwort
-
Immunoinformatics
Cancer--Immunotherapy
HLA ; Immunologie ; Bioinformatik
- Ereignis
-
Veröffentlichung
- (wo)
-
Tübingen
- (wer)
-
Universitätsbibliothek Tübingen
- (wann)
-
2018
- Urheber
- URN
-
urn:nbn:de:bsz:21-dspace-852706
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:27 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Backert, Linus
- Universitätsbibliothek Tübingen
Entstanden
- 2018
Ähnliche Objekte (12)
HLA Ligand Atlas: a benign reference of HLA-presented peptides to improve T-cell-based cancer immunotherapy
Acquired cancer resistance to combination immunotherapy from transcriptional loss of class I HLA
Immunopeptidomic Profiling of HLA‐A2‐Positive Triple Negative Breast Cancer Identifies Potential Immunotherapy Target Antigens
Identification of naturally presented immunogenic HLA ligands of prostate cancer and HCMV-infected cells for immunotherapy
Characterization of a murine TCR specific for HLA-A2.1 restricted non-mutated MDM2 peptide for cancer immunotherapy
Cancer immunology and immunotherapy
Immunotherapy of Colorectal Cancer
Neurology of cancer immunotherapy
Cancer immunology immunotherapy : CII
Immunotherapy in Ovarian Cancer
Bacteria‐Based Cancer Immunotherapy
Dynamic changes of soluble HLA-G and cytokine plasma levels in cervical cancer patients: potential role in cancer progression and immunotherapy
HLA Ligand Atlas: a benign reference of HLA-presented peptides to improve T-cell-based cancer immunotherapy
Acquired cancer resistance to combination immunotherapy from transcriptional loss of class I HLA
Immunopeptidomic Profiling of HLA‐A2‐Positive Triple Negative Breast Cancer Identifies Potential Immunotherapy Target Antigens
Identification of naturally presented immunogenic HLA ligands of prostate cancer and HCMV-infected cells for immunotherapy
Characterization of a murine TCR specific for HLA-A2.1 restricted non-mutated MDM2 peptide for cancer immunotherapy
Cancer immunology and immunotherapy
Immunotherapy of Colorectal Cancer
Neurology of cancer immunotherapy
Cancer immunology immunotherapy : CII
Immunotherapy in Ovarian Cancer
Bacteria‐Based Cancer Immunotherapy
Dynamic changes of soluble HLA-G and cytokine plasma levels in cervical cancer patients: potential role in cancer progression and immunotherapy
HLA Ligand Atlas: a benign reference of HLA-presented peptides to improve T-cell-based cancer immunotherapy
Acquired cancer resistance to combination immunotherapy from transcriptional loss of class I HLA
Immunopeptidomic Profiling of HLA‐A2‐Positive Triple Negative Breast Cancer Identifies Potential Immunotherapy Target Antigens
Identification of naturally presented immunogenic HLA ligands of prostate cancer and HCMV-infected cells for immunotherapy
Characterization of a murine TCR specific for HLA-A2.1 restricted non-mutated MDM2 peptide for cancer immunotherapy
Cancer immunology and immunotherapy
Immunotherapy of Colorectal Cancer
Neurology of cancer immunotherapy
Cancer immunology immunotherapy : CII
Immunotherapy in Ovarian Cancer
Bacteria‐Based Cancer Immunotherapy